Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease.
about
Walking speed: the functional vital signUnderstanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.Clinimetric properties of the Tinetti Mobility Test, Four Square Step Test, Activities-specific Balance Confidence Scale, and spatiotemporal gait measures in individuals with Huntington's diseaseEffects of a Two-Year Intensive Multidisciplinary Rehabilitation Program for Patients with Huntington's Disease: a Prospective Intervention StudySupporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trialSelf-Selected Walking Speed is Predictive of Daily Ambulatory Activity in Older AdultsEffects of a One Year Intensive Multidisciplinary Rehabilitation Program for Patients with Huntington's Disease: a Prospective Intervention Study.Physical Activity Self-Management and Coaching Compared to Social Interaction in Huntington Disease: Results From the ENGAGE-HD Randomized, Controlled, Pilot Feasibility Trial.Development of a community-based exercise program for people diagnosed and at-risk for Huntington's disease: A clinical report.The validity and reliability of the four square step test in different adult populations: a systematic review.Reliability of the timed 10-metre walk test during inpatient rehabilitation in ambulatory adults with traumatic brain injury.Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and RecommendationsCognitive-Motor Interference in Neurodegenerative Disease: A Narrative Review and Implications for Clinical Management
P2860
Q26821844-3200FD78-AC65-4759-AFF3-096777CA0F52Q34443430-44DFB0C1-CF1C-4FCF-AFA3-80C97A56E21AQ34502749-5F3136D3-F5A3-4DCB-9702-137F258BFEDBQ34642051-77E79082-5B83-4533-AA04-3EA45FBC0C4AQ34968069-D0A3927D-6DE8-4DDB-BB56-EF25E5E08805Q36689815-63BB6E03-4AFA-48C3-905D-BFB10351D9F2Q37409956-6EA7DCDA-4C8A-4F78-93AB-84F19AEFA21EQ38735691-A4F04FB1-BF2B-413E-8282-88EAA5FEE96FQ38798688-C4F18074-BA46-4FE9-B459-0B11E08C2A74Q41274077-FE743A84-669C-4E59-B38C-BFA014D2108BQ48281343-587E37BA-5894-4C45-841D-5DA7C88F6541Q49300979-013AB3B9-0A6E-4402-B693-1AC720ED5244Q58574520-33B534C0-9689-4510-BC55-9BBE410D632DQ58697865-81BC6C75-1671-44A3-8E32-78888F1290E6
P2860
Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Reliability and minimal detect ...... d manifest Huntington disease.
@en
Reliability and minimal detect ...... d manifest Huntington disease.
@nl
type
label
Reliability and minimal detect ...... d manifest Huntington disease.
@en
Reliability and minimal detect ...... d manifest Huntington disease.
@nl
prefLabel
Reliability and minimal detect ...... d manifest Huntington disease.
@en
Reliability and minimal detect ...... d manifest Huntington disease.
@nl
P2093
P50
P356
P1433
P1476
Reliability and minimal detect ...... d manifest Huntington disease.
@en
P2093
Anne D Kloos
Hanan Khalil
Jonathan W Gillard
Nora E Fritz
Outcome Measures Subgroup of the European Huntington's Disease Network
P304
P356
10.2522/PTJ.20130032
P577
2013-03-21T00:00:00Z